Evoke Pharma Stock Market Value
| EVOK Stock | USD 4.50 0.06 1.32% |
| Symbol | Evoke |
Evoke Pharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evoke Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evoke Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evoke Pharma.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Evoke Pharma on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Evoke Pharma or generate 0.0% return on investment in Evoke Pharma over 360 days. Evoke Pharma is related to or competes with Petros Pharmaceuticals, Cumberland Pharmaceuticals, Painreform, Aquestive Therapeutics, Regencell Bioscience, Procaps Group, and Incannex Healthcare. Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of dr... More
Evoke Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evoke Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evoke Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.0 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 48.38 | |||
| Value At Risk | (8.85) | |||
| Potential Upside | 6.2 |
Evoke Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evoke Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evoke Pharma's standard deviation. In reality, there are many statistical measures that can use Evoke Pharma historical prices to predict the future Evoke Pharma's volatility.| Risk Adjusted Performance | 0.0169 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.77) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0391 |
Evoke Pharma Backtested Returns
As of now, Evoke Stock is very risky. Evoke Pharma secures Sharpe Ratio (or Efficiency) of 0.0216, which denotes the company had a 0.0216% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Evoke Pharma, which you can use to evaluate the volatility of the firm. Please confirm Evoke Pharma's Mean Deviation of 3.99, coefficient of variation of 9457.88, and Downside Deviation of 5.0 to check if the risk estimate we provide is consistent with the expected return of 0.14%. Evoke Pharma has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.46, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Evoke Pharma will likely underperform. Evoke Pharma right now shows a risk of 6.3%. Please confirm Evoke Pharma semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Evoke Pharma will be following its price patterns.
Auto-correlation | 0.50 |
Modest predictability
Evoke Pharma has modest predictability. Overlapping area represents the amount of predictability between Evoke Pharma time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evoke Pharma price movement. The serial correlation of 0.5 indicates that about 50.0% of current Evoke Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.73 |
Evoke Pharma lagged returns against current returns
Autocorrelation, which is Evoke Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evoke Pharma's stock expected returns. We can calculate the autocorrelation of Evoke Pharma returns to help us make a trade decision. For example, suppose you find that Evoke Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evoke Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evoke Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evoke Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evoke Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Evoke Pharma Lagged Returns
When evaluating Evoke Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evoke Pharma stock have on its future price. Evoke Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evoke Pharma autocorrelation shows the relationship between Evoke Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Evoke Pharma.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Evoke Pharma Correlation, Evoke Pharma Volatility and Evoke Pharma Alpha and Beta module to complement your research on Evoke Pharma. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Evoke Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.